Evidence map›Paper›PMID 30580012›Full record

ReviewBrain research2019

Cell-type and projection-specific dopaminergic encoding of aversive stimuli in addiction.

Kimberly C Thibeault, Munir Gunes Kutlu, Christina Sanders, Erin S Calipari

Abstract readReview
In one paragraph

Review in Brain research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Addiction neuroscience · 2024
    Article
  8. Article
  9. Article
  10. Distinct Role of Dopamine in the PFC and NAc During Exposure to Cocaine-Associated Cues.The international journal of neuropsychopharmacology · 2021
    Article
  11. Sex differences in dopamine release regulation in the striatum.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2021
    Review
  12. Article
  13. Midbrain circuits of novelty processing.Neurobiology of learning and memory · 2020
    Review
  14. Article
  15. β2* nAChRs on VTA dopamine and GABA neurons separately mediate nicotine aversion and reward.Proceedings of the National Academy of Sciences of the United States of America · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Kimberly C ThibeaultVanderbilt Center for Addiction Research, Vanderbilt University School of Medicine, Nashville, TN 37232, USA; Vanderbilt Brain Institute, Vanderbilt University School of Medicine, Nashville, TN 37232, USA.
Munir Gunes KutluDepartment of Pharmacology, Vanderbilt University School of Medicine, Nashville, TN 37232, USA.
Christina SandersDepartment of Pharmacology, Vanderbilt University School of Medicine, Nashville, TN 37232, USA.
Erin S CalipariDepartment of Pharmacology, Vanderbilt University School of Medicine, Nashville, TN 37232, USA; Vanderbilt Center for Addiction Research, Vanderbilt University School of Medicine, Nashville, TN 37232, USA; Vanderbilt Brain Institute, Vanderbilt University School of Medicine, Nashville, TN 37232, USA. Electronic address: erin.calipari@vanderbilt.edu.

Funding

Training in Fundamental NeuroscienceT32MH064913 · NIMH · VANDERBILT UNIVERSITY · PI IHRIE, REBECCA A, WINDER, DANNY G. · 2001 to 2022
$7.6M
Making and breaking opioid memories to prevent relapseDP1DA048931 · NIDA · VANDERBILT UNIVERSITY · PI CALIPARI, ERIN · 2019 to 2023
$2.4M
Defining the Role of D1 and D2 Medium Spiny Neurons in Relapse to Cocaine SeekingR00DA042111 · NIDA · VANDERBILT UNIVERSITY · PI CALIPARI, ERIN · 2018 to 2020
$747k
Defining the Role of D1 and D2 Medium Spiny Neurons in Relapse to Cocaine SeekingK99DA042111 · NIDA · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI CALIPARI, ERIN · 2016 to 2017
$301k
NIDA NIH HHS DP1 DA048931NIDA NIH HHS K99 DA042111NIDA NIH HHS R00 DA042111NIMH NIH HHS T32 MH064913
6 · The paper itself

Abstract

Drug addiction is a major public health concern across the world for which there are limited treatment options. In order to develop new therapies to correct the behavioral deficits that result from repeated drug use, we need to understand the neural circuit dysfunction that underlies the pathophysiology of the disorder. Because the initial reinforcing effects of drugs are dependent on increases in dopamine in reward-related brain regions such as the mesolimbic dopamine pathway, a large focus of addiction research has centered on the dysregulation of this system and its control of positive reinforcement and motivation. However, in addition to the processing of positive, rewarding stimuli, there are clear deficits in the encoding and valuation of information about potential negative outcomes and how they control decision making and motivation. Further, aversive stimuli can motivate or suppress behavior depending on the context in which they are encountered. We propose a model where rewarding and aversive information guides the execution of specific motivated actions through mesocortical and mesolimbic dopamine acting on D1- and D2- receptor containing neuronal populations. Volitional drug exposure alters the processing of rewarding and aversive stimuli through remodeling of these dopaminergic circuits, causing maladaptive drug seeking, self-administration in the face of negative consequences, and drug craving. Together, this review discusses the dysfunction of the circuits controlling different types of aversive learning as well as how these guide specific discrete behaviors, and provides a conceptual framework for how they should be considered in preclinical addiction models.

Indexed as

AnimalsBehavior, AddictiveBrainDopamineDopaminergic NeuronsDrug-Seeking BehaviorHumansMotivationNucleus AccumbensReceptors, Dopamine D2Reinforcement, PsychologyRewardSubstance-Related DisordersDopamineReceptors, Dopamine D2Associative learningCocaineNucleus accumbensPrefrontal cortexPunishmentSelf-administration

Identifiers

PMID30580012
PMCPMC6506354

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.